Mani, Inc. (7730)

Name: Mani, Inc. (7730) — historial de estados financieros
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

Historial de ingresos, beneficios y flujo de caja según los estados financieros oficiales.

Healthcare · Wall Street (EE. UU.) · Última actualización: 2026-10-02

Mani, Inc. engages in the manufacture and supply of surgical and dental instruments in Japan, Asia, Europe, North America, and internationally. The company operates through three segments: Surgical Products, Eyeless Needle Products, and Dental Products. The company offers surgical instruments, such as maniplers, vessel knives, ENT knives, and stainless wire needles; and ophthalmic instruments, including ophthalmic sutures and knives, and trocar kits for vitrectomy.

Cifras clave

Capitalización bursátil: JPY 142 billion
Ingresos (ejercicio cerrado en 2025-08-31): JPY 30.0B
Beneficio neto: JPY 4.6B
Margen bruto: 64.5%
Margen neto: 15.5%

Ver gráficos interactivos y estados completos → Modelo de valoración (DCF) →

Cuenta de resultados anual

Cuenta de resultados	2025-08-31	2024-08-31	2023-08-31	2022-08-31
Ingresos totales	JPY 30.0B	JPY 28.5B	JPY 24.5B	JPY 20.4B
Beneficio bruto	JPY 19.3B	JPY 17.9B	JPY 15.4B	JPY 12.6B
Ingresos operativos (EBIT)	JPY 8.2B	JPY 8.4B	JPY 7.2B	JPY 6.2B
Ingresos netos	JPY 4.6B	JPY 6.3B	JPY 6.0B	JPY 5.3B

Fuente: informes públicos de la empresa (SEC). Verifique en SEC EDGAR antes de confiar en cualquier cifra.

Balances, flujos de caja, datos trimestrales y ratios completos en el visor interactivo de 7730. /companies/us/7730

Empresas similares

La información de este sitio es solo educativa e informativa; no constituye asesoramiento de inversión. No se publican precios objetivo ni recomendaciones.

English version →Todas las acciones

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.